Kemerovo

The trials here

What the 14 trials at this site are about, from their registry records.

Conditions

• Asthma5 trials
• Heart failure2 trials
• Lung cancer2 trials
• Atrial fibrillation1 trial
• Childhood cancers1 trial
• Chronic kidney disease1 trial
• COPD1 trial
• High blood pressure1 trial
• Lupus (SLE)1 trial
• Metastatic breast cancer1 trial
• Ventricular tachycardia1 trial

Phase

• Phase 32 trials
• Phase 2/31 trial

Status

• Completed8 trials
• Active, not recruiting3 trials
• Recruiting2 trials
• Terminated1 trial

Lead sponsor

• AstraZeneca14 trials

Running trials

• Recruiting

  ReAl-woRld Evaluation of tEzepelumab for Chronic rhinoSinusitis With Nasal Polyps in Russia

  NCT07399665· AstraZeneca· Source

• Active, not recruiting

  Clinical& Demographic Profiles of patIents With unControllEd Asthma in Russia: Multi-center oBsErvational ReGistry Study

  NCT06521229· AstraZeneca· Source

• Recruiting

  Clinical and demOgRaphic Features of Patients With Uncontrolled Severe Asthma in Russia (CORSAR)

  NCT06472310· AstraZeneca· Source

• Active, not recruiting

  Treatment and Biomarker Testing Patterns,Treatment Outcomes in a/m NSCLC With and Without Actionable Genomic Alterations

  NCT06245837· AstraZeneca· Source

• Active, not recruiting

  CRT( Chemo-Radiation Therapy) Patterns and Short-term Outcomes on Unresectable NSCLC and SCLC in Routine Practices in Russia

  NCT05887011· AstraZeneca· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Asthma2 recruiting

Closed trials

• Completed

  Study of Patient With Frequent COPD Exacerbations

  NCT07221981· AstraZeneca· Source

• Completed

  Real-world Study Assessing Efficacy of TezepeLumaB in Patients With Severe Asthma Regardless of Phenotype in Russia

  NCT06566885· AstraZeneca· Source

• Completed

  Clinical and Demographic Features of Patients With Moderate to Severe Active Systemic Lupus Erythematosus in Russia

  NCT06759519· AstraZeneca· Source

• Completed

  PRospectIve ObseRvatIonal mulTicenter Study of Patients With Arterial hYpertension and CKD in the Population of Russia

  NCT06372431· AstraZeneca· Source

• Completed

  HER2-low Unresectable and/or Metastatic Breast Cancer in Russia

  NCT05913440· AstraZeneca· Source

• Completed

  Study to Evaluate the Efficacy and Safety of AZD4831 in Participants With Heart Failure With Left Ventricular Ejection Fraction > 40%

  NCT04986202· Phase 2/3· AstraZeneca· Source

• Terminated

  Effect of Sodium Zirconium Cyclosilicate on Arrythmia-related Cardiovascular Outcomes in Participants on Chronic Hemodialysis With Recurrent Hyperkalemia (DIALIZE-Outcomes)

  NCT04847232· Phase 3· AstraZeneca· Source

• Completed

  Study to Assess PT010 in Adult and Adolescent Participants With Inadequately Controlled Asthma (LOGOS)

  NCT04609904· Phase 3· AstraZeneca· Source

• Completed

  Heart Failure Patients Registry

  NCT04709263· AstraZeneca· Source